Study on the Accuracy of cervical-thorax combined contrast-enhanced ultrasound in Investigating the Etiology of Cardiogenic Cerebrovascular Disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000041285

Enrollment

Unknown

Registered

2020-12-23

Start date

2020-04-30

Completion date

Unknown

Last updated

2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic Cerebrovascular Disease

Interventions

combined&#32

contrast-enhanced&#32

ultrasound

Gold Standard:TCD, TTE

Index test:cervical-thorax&#32

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Aged 18-55 years, unexplained stroke, transient ischemic attack, intractable migraine.

Exclusion criteria

Exclusion criteria: Can not cooperate with transesophageal ultrasound examination.

Design outcomes

Primary

Measure	Time frame
patent foramen ovale;Consistency;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactZhang Hui

The Third Affiliated Hospital of Sun Yat-Sen University

zhang9@mail.sysu.edu.cn+86 18620004402

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026